Recent Finacing
Recent Raise
EnteroBiotix is a clinical-stage biopharmaceutical company developing full-spectrum microbiome therapeutics, including lead candidate EBX-102-02 for irritable bowel syndrome.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
